Skip to content

Peanut protein detection in serum

Peanut protein detection in serum - PEANUTS Pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43466
Enrollment
10
Registered
2016-01-29
Start date
2016-02-10
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intestinal permeability Nutrient uptake

Interventions

Intake of 100 grams of peanuts

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 20-35 year old males and females - Body Mass Index (BMI) 18.5-25 kg/m2 - Suitable veins for blood sampling

Exclusion criteria

Exclusion criteria: - History of peanut allergy - Known symptoms of immune disease, such as diabetes, gastritis, and coeliac disease. - Known symptoms of intestinal disease, such as Crohn*s Disease, ulcerosis, and irritable bowel syndrome. - Smoking - Use of hard drugs - Use of specific drugs: Chronic use of NSAIDs: aspirins, ibuprofen, etc. - Drugs having an effect on gastric and/or intestinal function and motility, including antidepressants - Participation in other scientific studies (with the exception of EetMeetWeet) - Blood donation during the last six weeks before the start of the study

Design outcomes

Primary

MeasureTime frame
The primary parameter of the pilot study is the number of subjects in which Ara h6 in serum can be detected with the sandwich ELISA after peanut consumption

Secondary

MeasureTime frame
The secundary parameter of this pilot study are serum factors that could possibly influence the sensitivity of the analysis method, such as total peanut IgE and IgG(4)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)